Lower Serum P1NP/βCTX Ratio and Hypoalbuminemia Are Independently Associated with Osteoporotic Nonvertebral Fractures in Older Adults

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2017 Aug 4

PMID 28769558

Citations 12

Authors

Alexander Fisher

Wichat Srikusalanukul

Leon Fisher

Paul N Smith

Affiliations

Soon will be listed here.

Abstract

Purpose: To estimate the discriminative value of serum P1NP/βCTX ratio and albumin levels in hospitalized orthogeriatric patients with and without nonvertebral fractures.

Methods: In 1,239 orthogeriatric patients (mean age 78.1±9.52 years, 69.1% women) including 854 (68.9%) with osteoporotic nonvertebral fractures (455 [36.7%] with hip fracture [HF]) and 385 (31.1%) without fractures, markers of bone formation (procollagen type 1 N-terminal propeptide [P1NP], osteocalcin [OC], and bone resorption (beta-C-terminal cross-linking telopeptide of type 1 collagen [βCTX]), indices of mineral metabolism, and parameters of liver and renal functions were assessed; data on clinical and laboratory characteristics were collected prospectively.

Results: Both lower serum P1NP/βCTX ratio and albumin concentration (as continuous or categorical variables) were independently associated with fracture presence in multivariate logistic regressions. Compared with the highest P1NP/βCTX tertile, the prevalence of HF, after adjustment for multiple covariates, was 3-fold higher in the lowest tertile and 1.5 times higher in the middle tertile; presence of any fracture was 2.3- and 1.6-fold higher, respectively; patients with albumin levels in the lowest tertile had multivariate odds ratio (OR) of 4.6 for HF and 2.8 for any fracture, in the middle tertile the ORs were 2.2 and 1.3, respectively. The P1NP/βCTX <100.0 (median) and hypoalbuminemia (<33 g/L) demonstrated area under the curve values for HF of 0.802 and 0.806, respectively, and for any fractures of 0.711 and 0.706, respectively. When both characteristics were combined, the ORs for HF or any fracture, compared with the nonfractured group, were 7.8 and 3.2, respectively, with an accuracy of 79.6% and 71.6%, respectively.

Conclusions: In orthogeriatric patients, both serum P1NP/βCTX ratio and albumin levels demonstrated an inverse dose-effect relationship with the prevalence of nonvertebral fractures and independently indicated fracture presence with acceptable discriminatory power. Lower P1NP/βCTX (<100) and hypoalbuminemia could be useful simple additive prognostic tools for fracture risk stratification in the elderly.

Citing Articles

The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population.

Guo L, Zhang N, Fan X, Hou X, Li M, Xu W Osteoporos Int. 2025; .

PMID: 39982456 DOI: 10.1007/s00198-025-07428-x.

Abnormally low serum albumin levels are associated with abnormal bone mineral density and osteoporotic fractures: a retrospective studies.

Li Q, Zhu M, Liu X, Tian C, Li D, Wang H BMC Musculoskelet Disord. 2024; 25(1):888.

PMID: 39511536 PMC: 11542386. DOI: 10.1186/s12891-024-08021-9.

TRACP-5b/BAP Score After 3 Months of Treatment With Combined SERM/E2 Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia.

Ota I, Ota Y, Ota K, Eda H, Ohta H JBMR Plus. 2022; 6(11):e10690.

PMID: 36398113 PMC: 9664539. DOI: 10.1002/jbm4.10690.

Study on Risk Factors of Primary Non-traumatic OVCF in Chinese Elderly and a Novel Prediction Model.

Wen Z, Mo X, Zhao S, Qi Z, Fu D, Wen S Orthop Surg. 2022; 14(11):2925-2938.

PMID: 36168985 PMC: 9627056. DOI: 10.1111/os.13531.

Acute Effects of Strength and Endurance Training on Bone Turnover Markers in Young Adults and Elderly Men.

Stunes A, Brobakken C, Sujan M, Aagard N, Brevig M, Wang E Front Endocrinol (Lausanne). 2022; 13:915241.

PMID: 35846315 PMC: 9279869. DOI: 10.3389/fendo.2022.915241.

References

Ma M, Yap D, Yip T, Lui S, Lo W . Charlson co-morbidity index and albumin significantly associated with fracture risk in peritoneal dialysis patients. Nephrology (Carlton). 2013; 18(5):365-8. DOI: 10.1111/nep.12056. View

Finnes T, Lofthus C, Meyer H, Eriksen E, Apalset E, Tell G . Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study. Bone. 2014; 64:1-7. DOI: 10.1016/j.bone.2014.03.010. View

Dagan N, Cohen-Stavi C, Leventer-Roberts M, Balicer R . External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study. BMJ. 2017; 356:i6755. PMC: 5244817. DOI: 10.1136/bmj.i6755. View

Ikegami S, Kamimura M, Nakagawa H, Takahara K, Hashidate H, Uchiyama S . Comparison in bone turnover markers during early healing of femoral neck fracture and trochanteric fracture in elderly patients. Orthop Rev (Pavia). 2011; 1(2):e21. PMC: 3143987. DOI: 10.4081/or.2009.e21. View

Morris H, Eastell R, Jorgensen N, Cavalier E, Vasikaran S, Chubb S . Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clin Chim Acta. 2016; 467:34-41. DOI: 10.1016/j.cca.2016.06.036. View

Obrant K, Ivaska K, Gerdhem P, Alatalo S, Pettersson K, Vaananen H . Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone. 2005; 36(5):786-92. DOI: 10.1016/j.bone.2005.02.009. View

Shigdel R, Osima M, Ahmed L, Joakimsen R, Eriksen E, Zebaze R . Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures. Bone. 2015; 81:1-6. DOI: 10.1016/j.bone.2015.06.016. View

Eastell R, Barton I, Hannon R, Chines A, Garnero P, Delmas P . Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res. 2003; 18(6):1051-6. DOI: 10.1359/jbmr.2003.18.6.1051. View

Ivaska K, Gerdhem P, Akesson K, Garnero P, Obrant K . Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res. 2007; 22(8):1155-64. DOI: 10.1359/jbmr.070505. View

10.

Kanis J, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E . FRAX and its applications to clinical practice. Bone. 2009; 44(5):734-43. DOI: 10.1016/j.bone.2009.01.373. View

11.

Kanis J, Harvey N, Cooper C, Johansson H, Oden A, McCloskey E . A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016; 11(1):25. PMC: 4978487. DOI: 10.1007/s11657-016-0278-z. View

12.

Akesson K, Kakonen S, Josefsson P, Karlsson M, Obrant K, Pettersson K . Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis. J Bone Miner Metab. 2004; 23(1):30-5. DOI: 10.1007/s00774-004-0537-8. View

13.

Szulc P, Montella A, Delmas P . High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study. Ann Rheum Dis. 2007; 67(9):1249-55. DOI: 10.1136/ard.2007.077941. View

14.

Garnero P . Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008; 12(3):157-70. DOI: 10.1007/BF03256280. View

15.

Johansson H, Oden A, Kanis J, McCloskey E, Morris H, Cooper C . A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. 2014; 94(5):560-7. DOI: 10.1007/s00223-014-9842-y. View

16.

Leslie W, Lix L . Comparison between various fracture risk assessment tools. Osteoporos Int. 2013; 25(1):1-21. DOI: 10.1007/s00198-013-2409-3. View

17.

Ivaska K, Gerdhem P, Vaananen H, Akesson K, Obrant K . Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res. 2009; 25(2):393-403. DOI: 10.1359/jbmr.091006. View

18.

Melton 3rd L, Atkinson E, Achenbach S, Kanis J, Therneau T, Johansson H . Potential Extensions of the US FRAX Algorithm. J Osteoporos. 2012; 2012:528790. PMC: 3426248. DOI: 10.1155/2012/528790. View

19.

Vasikaran S, Chubb S . The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine. 2016; 52(2):222-5. DOI: 10.1007/s12020-016-0900-2. View

20.

Biver E . Use of bone turnover markers in clinical practice. Curr Opin Endocrinol Diabetes Obes. 2012; 19(6):468-73. DOI: 10.1097/MED.0b013e3283591492. View